Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients

Diabetologia
G A BrunnerT R Pieber

Abstract

The AERx insulin Diabetes Management system (AERx iDMS) is a liquid aerosol device that enables insulin to be administered to the peripheral parts of the lung. This study aimed to compare the pharmacokinetic and pharmacodynamic properties of insulin which is inhaled using AERx iDMS with insulin which is subcutaneously administered. In total, 18 C-peptide negative patients with Type I (insulin-dependent) diabetes mellitus participated in this randomised, open-label, 5-period crossover trial. Human regular insulin was administered subcutaneously (0.12 U/kg body weight) or inhaled by means of the AERx iDMS (dosages 0.3, 0.6, 1.2, and 1.8 U/kg body weight). Thereafter plasma glucose was kept constant at 7.2 mmol/l for a 10-h period (glucose clamp technique). Inhaled insulin provided a dose-response relation that was close to linear for both pharmacokinetic (AUC-Ins(0-10 h); Cmax-Ins) and pharmacodynamic (AUC-GIR(0-10 h); GIRmax) parameters. Time to maximum insulin concentration (Tmax-Ins) and time to maximum glucose infusion rate (TGIRmax) were shorter with inhaled insulin than with subcutaneous administration. The pharmacodynamic system efficiency of inhaled insulin (AUC-GIR(0-6 h) was 12.7% (95% C.I.: 10.2-15.6). The inhalation o...Continue Reading

Citations

Nov 15, 2005·Journal of Pharmacokinetics and Pharmacodynamics·Mathangi GopalakrishnanJogarao V S Gobburu
Aug 12, 2006·Pharmaceutical Research·Eva BondessonPer Wollmer
Oct 6, 2004·Current Diabetes Reports·Kjeld Hermansen
Jun 1, 2005·Archives of Medical Research·Francisco J Gómez-Pérez, Juan A Rull
Oct 11, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Henderik W Frijlink
Nov 27, 2002·Diabetes Technology & Therapeutics·Andreas PfütznerSolomon S Steiner
Nov 27, 2002·Diabetes Technology & Therapeutics·Lutz Heinemann
Oct 25, 2002·Diabetes Technology & Therapeutics·John ThipphawongStephen J Farr
Aug 24, 2004·Diabetes Technology & Therapeutics·Christoph KapitzaTim Heise
May 1, 2004·Diabetes Technology & Therapeutics·Christoph KapitzaLutz Heinemann
Feb 3, 2005·Diabetes Technology & Therapeutics·J A CramerP Clauson
Jul 10, 2007·Diabetes Technology & Therapeutics·Per WollmerStephen Brunton
Jul 10, 2007·Diabetes Technology & Therapeutics·S Edwin FinebergNaomi S Fineberg
Jul 10, 2007·Diabetes Technology & Therapeutics·Sunder Mudaliar, Robert R Henry
Mar 18, 2010·Vascular Health and Risk Management·Lucy D Mastrandrea
Mar 19, 2003·Drugs & Aging·Joël Belmin, Paul Valensi
May 19, 2005·Treatments in Endocrinology·Igor Alexander Harsch
Feb 1, 2008·Expert Review of Pharmacoeconomics & Outcomes Research·Bastiaan E de Galan
Sep 14, 2007·Expert Review of Medical Devices·Julio RosenstockJennifer Schmitke
Feb 4, 2003·Expert Opinion on Pharmacotherapy·Juan José Díez, Pedro Iglesias
Dec 2, 2004·Expert Opinion on Pharmacotherapy·Teresa Quattrin
Dec 23, 2006·Expert Opinion on Drug Delivery·Rucha JaniRalph A Defronzo
Oct 10, 2007·Expert Opinion on Investigational Drugs·Sunder Mudaliar
Oct 27, 2012·Expert Opinion on Drug Delivery·Sandra SoaresBruno Sarmento
Jun 22, 2006·Expert Opinion on Investigational Drugs·Samuel Edwin Fineberg
Dec 9, 2014·Expert Opinion on Drug Delivery·Jahidur RashidFakhrul Ahsan
Nov 22, 2005·Expert Opinion on Drug Delivery·Andreas Pfützner, Thomas Forst
Oct 11, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·F DepreterK Amighi
Oct 23, 2010·Revue des maladies respiratoires·M-H Becquemin, J-P Chaumuzeau
Nov 30, 2006·Diabetes & Metabolism·V Lassmann-Vague, D Raccah
Sep 21, 2007·Advanced Drug Delivery Reviews·El-Sayed KhafagyKozo Takayama
May 8, 2007·Diabetes Research and Clinical Practice·Simon HellerPeter Kurtzhals
Jan 24, 2007·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Astrid H PetersenPer Wollmer
Jun 24, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·K RaveD Muchmore
Nov 25, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·D R OwensG Bolli
Sep 4, 2007·British Journal of Clinical Pharmacology·Astrid H PetersenThomas R Pieber
Oct 31, 2006·Advanced Drug Delivery Reviews·Lucy D Mastrandrea, Teresa Quattrin
Jul 1, 2005·Metabolism: Clinical and Experimental·Paolo PozzilliPankaj Modi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.